UBS’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$32K Buy
48
+21
+78% +$16.8K ﹤0.01% 7382
2014
Q2
$25K Buy
27
+13
+93% +$11.9K ﹤0.01% 7788
2014
Q1
$16K Sell
14
-62
-82% -$53.6K ﹤0.01% 8363
2013
Q4
$33K Buy
76
+70
+1,167% +$43K ﹤0.01% 7504
2013
Q3
$7K Sell
6
-2
-25% -$3.04K ﹤0.01% 9119
2013
Q2
$12K Buy
+8
New +$15.4K ﹤0.01% 8430

Other funds holding CVM

UBS's CVM Position: Q3 2014 in Review

UBS increased its CEL-SCI Corp (CVM) stake by 78% in Q3 2014, buying an estimated $16.8K and bringing the position to 48 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #7382.

UBS first reported a position in CVM in Q2 2013 and has held it in 6 quarters since. The position peaked at $33K in Q4 2013. 26 funds tracked by Wall St. Rank hold CVM as of Q3 2014.

  • UBS held 48 shares of CEL-SCI Corp worth $32K as of Q3 2014.
  • UBS bought 21 CEL-SCI Corp shares in Q3 2014, an estimated $16.8K.
  • CEL-SCI Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7382 holding.
  • UBS first reported a position in CEL-SCI Corp in Q2 2013 and has held it in 6 quarters since.
  • UBS's CEL-SCI Corp position peaked at $33K in Q4 2013.
  • 26 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.